PTGS2 and head and neck squamous cell carcinoma: Therapeutic attempts to block PGE2-mediated immunosuppression in vivo using COX-2 inhibitors in a mouse model of HNSCC induced antitumor effects and restored antitumor immunity [55], thus highlighting its relevant role in immune escape.